Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : says COVID-19 vaccine more than 90% effective at protecting kids from infection, ahead of public review

10/22/2021 | 07:50am EST

WASHINGTON (AP) — Pfizer says COVID-19 vaccine more than 90% effective at protecting kids from infection, ahead of public review.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about PFIZER, INC.
12:04pTheranos founder Elizabeth Holmes to face cross-examination at fraud trial
RE
11:20aU.S. FDA panel weighs Merck's COVID-19 antiviral drug
RE
10:43aGLOBAL MARKETS LIVE : Amazon, Microsoft, Volvo, Glencore, Regeneron...
09:33aPfizer, NiKang Therapeutics to Study Combination Therapies to Treat Kidney Cancer
MT
09:32aThinking about trading options or stock in Vir Biotechnology, Novavax, Applied Material..
PR
09:23aGSK Brings In Pfizer Executive As New Head Of Vaccines R&D Unit
MT
09:17aWALL STREET STOCK EXCHANGE : Questions about Omicron and vaccine efficiency rattle markets
08:57aHealth Care Stocks Mixed Ahead of Tuesday Opener
MT
08:51aModerna CEO Says Booster Shots For Omicron Could Need Double Dosage
MT
08:15aPFIZER'S DORMITZER LEAVES FOR GLAXOS : Financial Times
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 13,5x
Yield 2021 3,01%
Capitalization 294 B 294 B -
EV / Sales 2021 3,95x
EV / Sales 2022 3,71x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 52,40 $
Average target price 49,58 $
Spread / Average Target -5,39%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.42.35%294 114
JOHNSON & JOHNSON1.16%420 557
ROCHE HOLDING AG15.70%334 662
NOVO NORDISK A/S67.75%247 392
ELI LILLY AND COMPANY50.93%231 027
ABBVIE INC.9.09%206 648